Augliff 1.2 Injection
Marketer
Elcliff Formulations Pvt Ltd
Salt Composition
Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Overview Augliff 1.2 Injection
Penbritin 1.2 Injection, a penicillin-based antibiotic, combats bacterial infections. It's indicated for treating lung infections (pneumonia, for example), ear, sinus, urinary tract, skin, and soft tissue infections. It's ineffective against viral illnesses like the common cold. Administration should always be performed by a medical professional; self-injection is prohibited. Dosage and frequency are determined by your physician based on your condition's severity, and adherence to their prescribed regimen is crucial. Typical side effects include nausea, vomiting, diarrhea, and oral thrush. Injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical attention. Individuals with severe liver or kidney impairment should consult their doctor prior to treatment initiation. Pre-treatment disclosure of antibiotic allergies or kidney/liver issues is essential; your doctor may adjust the dosage or select an alternative medication. Generally considered safe for use during pregnancy and breastfeeding under medical supervision.
Primary Ingredients of Augliff 1.2 Injection
No text was provided to rewrite.
Uses of Augliff 1.2 Injection
Preventing bacterial infections linked to surgical procedures
Major Benefits of Augliff 1.2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Augliff 1.2 Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Augliff 1.2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Augliff 1.2 Injection works:
Augliff 1.2 Injection unites Amoxycillin, a bacterial growth inhibitor, with Clavulanic Acid, a beta-lactamase inhibitor. Amoxycillin functions by disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Clavulanic Acid counteracts bacterial resistance mechanisms, thereby boosting Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Augliff 1.2 Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Augliff 1.2 is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Augliff 1.2 presents no known breastfeeding contraindications. Research in human subjects indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Augliff 1.2 Injection can produce adverse reactions that might impair driving ability. These reactions may include allergic responses, vertigo, or seizures, rendering driving unsafe.
KidneyCAUTION
Patients with kidney impairment should receive Augliff 1.2 Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use; consult a physician before administering.
LiverCAUTION
For individuals with hepatic impairment, administration of Augliff 1.2 Injection requires careful consideration. Dosage modification of Augliff 1.2 Injection might be necessary. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.
What if you forget to take Augliff 1.2 Injection :
Should you forget a dose of Augliff 1.2 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Augliff 1.2 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently